Objectives-To determine the proportion and features of invasive interval cancers that could be considered detectable at the time of the previous screen and the proportion of cases that could be classified as true intervals, false negatives, minimal signs, or radiographically occult lesions. Setting-BreastScreen Victoria, the Victorian component of the BreastScreen Australia mammography screening programme. Methods-Two separate review methodologies were adopted. Firstly a blinded review of interval, screen detected, and normal cases was undertaken, followed by a confirmation exercise to determine the proportion of invasive interval cancers that could be considered detectable at the time of the previous screen. Secondly, an unblinded review was performed to classify interval cases as true interval, false negative, minimal signs, or radiographically occult. Results-From the blinded review, it was estimated that 38% of interval cases may be considered "potentially detectable" at the time of screening. Comparison of the characteristics of interval and screen detected cases indicates that interval cases are more likely to be smaller, equivocal, ill defined masses. In the unblinded exercise, 41% of interval cases were classified as false negatives and a further 16% as minimal signs, 33% true intervals, and 10% radiographically occult. Of the interval cancers considered potentially detectable at screening, 97% were classified as false negatives in the unblinded review. Conclusions-This study highlights the importance of adopting staged review methods with both blinded and unblinded components. The blinded review and confirmation exercise allows the determination of the proportion of interval cases that could be considered potentially detectable at screening. The unblinded review provides an active important opportunity for professional development and review and a mechanism to link into the blinded review through further classification of interval cases. (J Med Screen 2000;7:184-189) 
An eVective population based breast cancer screening programme requires the participation of a large proportion of women in the eligible age range, an appropriate screening interval, and the provision of high quality mammography, radiology, and clinical investigation to the point of definitive diagnosis. As the proportion of invasive cancers diagnosed outside a screening programme as the result of symptomatic presentation increases, the potential benefit of early detection and treatment for the population is lessened.
Breast cancer detected in women who choose to attend the screening programme consists of diagnoses in both women within the programme at a two yearly screen and women during the interval after a negative screen and before the next scheduled screening examination. Review and analysis of interval cancers is an important component of quality assurance activities in a screening programme to (a) define the proportion of tumours for which screen detection may in fact have been achievable and (b) devise ways of addressing this issue through programme policy and improved mammographic interpretation.
It is expected that a number of interval cancers will be visible on previous screening films when viewed in retrospect. It is diYcult though to interpret results from retrospective reviews in terms of implications for earlier detection of breast cancer for women attending for screening. 1 The most significant challenge is adopting a method that will provide results that reflect the limitations of everyday practice and also identify areas where this practice can be improved. Results from unblinded reviews of interval cancers may represent an artificial method of determining the limitations of a screening programme as opposed to the true capacity for improvement. These reviews are likely to be biased towards the identification of suspicious lesions on the previous screening mammograms which are unlikely to represent cases that in a true screening situation could be considered potentially detectable at screening. 2 In this study we have addressed these issues by the adoption of staged review methods incorporating both blinded and unblinded review methods as recommended by Duncan et al. 3 Methods BREASTSCREEN VICTORIA PROGRAMME BreastScreen Victoria is the Victorian component of the national population based breast cancer screening programme, BreastScreen Australia. BreastScreen Victoria was initiated after a pilot programme in 1988-1990, with the statewide programme being phased in from 1992 to 1995. The programme now operates a network of eight screening and assessment services with 32 fixed and mobile screening sites, which provide free mammography screening to women aged 40 years and older at two yearly intervals. Women aged 50-69 years are the primary target age group of the screening programme and are actively recruited into the programme. The programme is designed for asymptomatic women and operates in accordance with the National Accreditation Requirements of BreastScreen Australia. 4 The programme accepts but does not encourage women with breast symptoms to attend for screening. Women undergo two view mammography (mediolateral oblique and craniocaudal views), and all mammograms are independently read by two radiologists, with recall for further assessment of any suspicious lesions detected during film reading. In cases where the recommendations of the two radiologists are discordant, a consensus or third independent read is performed to determine the outcome. All procedures up to definitive diagnosis of breast cancer are undertaken within the BreastScreen Victoria Programme.
OBJECTIVES
The objectives of this study were twofold, firstly to determine the proportion of invasive interval cancers that could be considered detectable at the time of the previous screen, and secondly to determine the proportion of cases that could be classified as true intervals, false negatives, minimal signs, or radiographically occult. To do this, we undertook a blinded review of previous screening films from invasive interval cases mixed with screen detected and normal cases and also an unblinded review of interval cases. The Radiology Quality Assurance Group comprising the eight chief radiologists from each of the BreastScreen Victoria screening and assessment services participated in the reading exercises. This group meets on a regular basis to address issues of continuing performance and quality of radiology within the Victorian programme.
Women who were not resident in Victoria or who reported symptoms (breast lump, watery or blood stained nipple discharge) or a personal history of breast cancer at the time of screening were excluded from this study. All cases were derived from the population of women attending for their first screen within the BreastScreen Victoria programme in 1994. Screen detected cases included invasive breast cancer diagnosed during the 1994 screening episode. Normal screens comprise women who were cleared at screening or after assessment in 1994 and who did not develop breast cancer in the interval between screens or at the subsequent biennial screening examination (97% of these women were regarded as normal at screening and 3% were declared normal after recall for further assessment). Interval cancers are described as cases of invasive breast cancer diagnosed within 24 months of a first round screen in women who did not have a diagnosis of invasive cancer or ductal carcinoma in situ after screening and any further assessment (87% of these women were regarded as normal at screening and 13% were declared normal after recall for further assessment). The method for the ascertainment of interval cancers has been described elsewhere. 5 Information on tumour grade, nodal involvement, and date of diagnosis was obtained as part of a routine link between the Victorian BreastScreen Registry and the population based Victorian Cancer Registry. Further information on variables of interest routinely collected at the time of screening was sourced from the BreastScreen Victoria programme. These variables included current use of hormone replacement therapy and age at screening.
BLINDED REVIEW
A blinded independent review was undertaken based on the method adopted by Day et al 6 to determine the proportion of cases visible on retrospective review and the radiological features of these lesions.
The screening films of 327 women were reviewed, consisting of a random mix of screen detected cancers (n = 99), interval cases (n = 129), and normal screens (n = 99). These cases were randomly selected from the seven screening and assessment centres operating within BreastScreen Victoria during 1994. A panel of five radiologists (JC, JE, AR, RT, LW) who were unaware of the outcome of screening for each case reviewed the mediolateral oblique and craniocaudal views of each breast taken at the screening visit in 1994. Although blinded to the category of each case and to the proportion of interval, screen detected, and normal cases in the batch of films reviewed, the radiologists were aware of the purpose of the exercise as a review of interval cancers.
The readers classified each case as clear, recall or technical recall (where image quality was deemed too poor to make a decision) and graded according to the following scale: 1, no specific abnormality; 2, benign; 3, equivocal; 4, suspicious lesion; 5, malignant lesion. For all cases marked as recall, a worksheet was completed in which readers indicated on diagrams of each mammographic view the site of the lesion and further information on mammographic size and classification of each lesion (discrete mass with/without calcification, nonspecific density, architectural distortion, spiculate mass, calcification, multiple masses). 4 Recommendations for recall are reported according to the number of readers recommending recall and combined results (recommendation for recall by three or more of the five radiologists).
Diagnostic information to ascertain the site of the interval lesion at the time of diagnosis was requested through the Victorian Cancer Registry for the interval cancer cases included in the review. Radiology practices were requested to provide diagnostic mammograms or radiology reports of the mammograms performed at the time of diagnosis of the interval lesion. If this information was unavailable, a request was made to the treating surgeon for details of the site of the lesion at diagnosis and further information on the size and nature of the lesion. Of the 129 interval cancers selected, diagnostic information was provided for 106 cases (82%).
Three radiologists not involved in the blinded review (RB, CT, NW) undertook a confirmation exercise of all interval cases for which a recommendation for recall had been made by one or more radiologists in the blinded review and for which diagnostic information was available. The 1994 screening mammograms, diagnostic information, and readers' worksheets from the independent review were examined to determine whether the lesions recommended for recall corresponded to the interval lesions at diagnosis.
For screen detected cases, those that were recommended for recall were cross checked with the information collected on the Breast-Screen Victoria database related to size, laterality, and classification of lesion to confirm that the lesions identified in the blinded review corresponded to the invasive lesions at diagnosis.
UNBLINDED REVIEW
The second review method adopted involved an unblinded consensus exercise by five radiologists (JC, JE, AR, RT, LW). The screening films and diagnostic information of all interval cases for which diagnostic information was available were reviewed (n = 106). With full knowledge of the site of the lesion at diagnosis, the group reached consensus as to the appropriate classification of each case as true interval, false negative, minimal signs, radiographically occult, or unclassifiable as described below. Consensus in this exercise constituted agreement by three or more of the five radiologists as to the appropriate classification of each interval case.
True intervals are cases that are not detectable at the time of screening but visible by mammography at the time of diagnosisthat is, cases arising in the interval after a true negative screen. True intervals are an inevitable part of any screening programme and the rate is determined purely by the length of the screening interval. Cases classified as false negatives include those where the lesion is visible on retrospective review of the previous screening mammograms and deemed to have been potentially detectable at that time. The classification minimal signs represents cases where more subtle mammographic changes are observed on the previous screening mammograms that are deemed to be not suspicious. Radiographically occult tumours are undetectable by mammography-that is, there is no mammographic abnormality present at the time of screening or diagnosis-and hence represent the ultimate limitation of a programme using mammography as the primary screening tool. Cases were deemed unclassifiable if the diagnostic information available was insuYcient to allow classification of the case.
The unblinded review permits the classification of each interval case and, further, is the most commonly adopted review method from previously published studies of interval cancers and allows comparison of the Victorian programme with these results.
STATISTICAL METHODS
We calculated the proportion of women recalled in the blinded review by category (normal, screen detected, interval cancer) and number of radiologists recommending recall and also present the results summarised as recalls by three or more radiologists. Further, the proportion of interval cases recalled in the unblinded review and confirmed as the interval lesion is presented. The characteristics of confirmed interval and screen detected lesions are presented as proportions with comparison of characteristics performed using the Pearson's 2 test by reader. These results were not combined for all readers as each reader recalled a diVerent combination of screen detected cancers and interval cases, some of which were subsequently confirmed as potentially detectable. In addition, the style and pattern of interpretation varies between diVerent readers. The results were thus analysed by each individual reader for all screen detected cases and interval cases which were subsequently confirmed. Where there were small numbers, the Fisher's exact test was used and all significance testing was two sided. All 95% confidence intervals are calculated according to the binomial exact method.
ETHICAL APPROVAL
Ethical approval for this study was obtained from the Anti-Cancer Council of Victoria institutional ethics committee. Table 1 presents recommendations for recall in the independent review by number of radiologists. Three or more radiologists recommended recall for 13% of normal cases. The corresponding rate for screen detected cases was 97% and cases that later presented as interval cancers at 49%. The results of Day et al 6 are presented for comparison. 
Results

BLINDED REVIEW
CONFIRMATION OF LESIONS RECALLED
Of the 105 interval cancer cases recalled by one or more radiologists, there was suYcient diagnostic information available to determine the site of the interval lesion for 80 cases (76.2%). Upon review, the lesion identified in the blinded review did not correspond to the lesion at diagnosis for any of the five radiologists for 31 cases (38.8%). These cases were more likely to have been recalled in the blinded review by one or two radiologists only (64.5%). Of the 49 cases for which the lesion identified on the screening films was confirmed as the interval lesion, 12 (24%) were correctly identified by one or two radiologists and 37 (76%) by three to five radiologists in the initial review. Therefore of all interval lesions recalled, the proportion of cases for which recall was correctly recommended on the basis of identification of a suspicious lesion by three to five radiologists is 46% (37 of 80 cases with information available). Extrapolating this information to assume that about 46% of all intervals that were recalled by one or more radiologists in the blinded review exercise would be confirmed for three to five radiologists if diagnostic information was available for all cases, this would correspond to a revised estimate of the recall rate from the blinded review from 48.8 to 37.6%-that is, about 38% of interval lesions may be deemed to have been potentially detectable at the time of screening. The validity of this assumption depends on there being no significant diVerence between the nature of interval lesions between those for which there was diagnostic information available and those for which confirmation was not possible. Of the 97 screen detected cases recommended for recall by one or more radiologists in the blinded review, the lesions were correctly identified for all 97 cases, with 93 cases (96%) recalled by three or more radiologists.
Characteristics of interval and screen detected lesions that were correctly identified in the blinded review were analysed by reader. For all readers, a significantly greater proportion of interval lesions were classified as grade 3 (equivocal) and screen detected lesions as grade 5 (malignant) (p<0.0001). For all readers, the mammographic size was recorded as less than 15 mm for a greater proportion of interval cases than screen detected cases but this was only significant for readers D and E (p<0.05). Comparison of the lesion classification for interval and screen detected cases indicates a greater proportion of intervals classified as non-specific density while most screen detected cases were classified as spiculate mass (readers A, B, C, E) or discrete mass (reader D) (p<0.0001, all readers). For reader A, interval lesions were more likely to be seen on one view only than on both views (p = 0.001). Table 2 outlines the classification of interval cases from the unblinded review of interval cases. Ten of the 106 cases were unclassifiable. Of the remaining 96 cases, 39 (41%) were classified as false negatives, with a further 16% as minimal signs. True intervals comprised about 33% of intervals reviewed, with the remainder of cases classified as radiographically occult (10%).
UNBLINDED REVIEW
Of the 96 interval cases considered classifiable, 25% of cases in women taking hormone replacement therapy and 48% in women not taking hormone replacement therapy were classified as false negatives (p<0.05). There was no significant diVerence between the profile of false negative cases and the other classifications of interval cancers by tumour grade, size, nodal status, and delay to diagnosis, although these comparisons may be hampered by the small samples once stratified. Table 3 presents the classification in the unblinded review of the 80 interval cases that were recalled in the blinded review and for which diagnostic information was available. Of the 37 cases that were deemed potentially detectable at screening in the blinded review and confirmation exercise, 36 (97%) were classified as false negatives and one as unclassifiable in the unblinded review.
COMPARISON OF BLINDED AND UNBLINDED
REVIEW OUTCOMES
Discussion
This study highlights the significant issues arising from the interpretation of results obtained from retrospective analyses of interval cancers. The results of each review process provide insight into this issue and when both are performed provide a more accurate measure of the limitations of the programme.
Comparison of the results of the blinded review with those of Day et al 6 indicate that the performance of the Victorian programme is similar to that reported for the East Anglian screening programme. Although not statistically significant, a lower proportion of interval cancers were recalled on blinded review in the BreastScreen Victoria review. This may indicate that there is a lower proportion of interval cancers that may be considered potentially detectable at the time of screening in the Victorian programme. This study has taken these results one step further by the independent confirmation of lesions identified in the blinded review to allow the determination of the proportion of interval cancers where a lesion was visible in retrospect which further corresponds to the interval lesion at the time of diagnosis. It may be suggested that the estimate of 38% of interval cases that were identified correctly on blinded review provides the most accurate indication of the proportion of interval cancers that may truly be considered potentially detectable at the time of screening. However, these results were obtained with a group of radiologists with a great deal of experience in screening and assessment within the BreastScreen Victoria Programme under study conditions. These may not reflect achievable results in the true screening setting where it may be expected that that proportion of potentially detectable interval cancers would be lower in view of the wide range of experience in practice.
Comparison of the characteristics of confirmed intervals with screen detected cases indicates that interval cases are more likely to be smaller, equivocal, ill-defined masses. This indicates that these cases do not merely represent cancers that are overlooked at screening, but also that a subset of these cases are probably more diYcult to detect. These results correspond to those reported by Goergen et al 7 showing that cancers identified by one reader only at the time of screening were more likely to be smaller low density lesions visible on one view only.
UNBLINDED REVIEW
Several studies have published the results of review processes adopted to classify interval cancers as true intervals, false negatives, minimal signs, and occult. These studies often vary with respect to the methods of reviewing and the definitions applied for the ascertainment of interval cancers and the classification of those cases. Further diVerences relate to the screening programmes, eligibility criteria, screening interval, and mode and represent further limitations to the comparability of these studies. Table 4 presents the results from this study with those of comparable reviews in terms of stratification by time after screening and definition applied for the classification of cases. Although it is diYcult to compare the results because of small sample sizes and the limitations mentioned above, it appears that the proportion of false negative cases identified in this study is similar to that reported in these studies.
A number of studies have looked at the prospective classification of minimal signs and increased follow up and subsequently the implications of this practice for improved detection of breast cancer. These studies have indicated that there were no grounds on which to recall these women for further assessment but rather the likely outcome is an increase in false positives and unnecessary investigations with only a minimal improvement in sensitivity. [8] [9] [10] This study further supports these findings, as none of the cases deemed to be potentially detectable at screening were classified as minimal signs. Despite the greater potential for bias in the unblinded review exercise, there were similar findings between the two review processes with respect to the high proportion of cases deemed potentially detectable that were subsequently identified as false negatives in the unblinded review.
IMPROVEMENT OF MAMMOGRAPHIC
INTERPRETATION
Reasons for imprecision in interpretation are often thought to be lack of experience and lack of mammography specific training. 11 Several programmes have considered ways of maximising the detection of cancers present at the time of screening and minimising interval cancers. Of these initiatives, those that have been an operational part of the BreastScreen Victoria programme since its inception include the use of two view mammography and two radiologist readers. Additional ways suggested to address these issues include the incorporation of measures of breast density and reader confidence in the screening result, consideration of physical examination as a routine adjunct to mammography, the performance of baseline mammograms at younger ages, and provision of additional training in the detection of subtle mammographic signs. 12 13 It is diYcult to determine appropriate steps to take to this end, particularly changes that would involve a significant change to current screening practice, such as the performance of baseline mammography or addition of physical examination where evidence of benefit is unclear. In addition, it is most important to maintain an appropriate balance between sensitivity and specificity. Lowering the threshold for recall in order to improve sensitivity will result in the unnecessary recall of a number of women who do not in fact have breast cancer. For a programme that is aimed at a well population of women, minimising the negative aspects of screening for the vast majority of attendees is extremely important.
Performance of reviews and exercises such as this and communication of the results in various fora within the screening programme are ideal ways of initiating discussion and professional development in the area of improved mammographic interpretation. Further work underway within the Victorian programme at present includes the development of a specialised screening mammography training facility for radiologists working within the Breast-Screen Victoria programme to enhance the exchange of information and professional development and ultimately improve the detection of breast cancer within the programme.
